Abstract
Pretreatment with GABA (250–1,000 mg/kg, IP) potentiated the cataleptogenic effect of haloperidol in a dose-dependent manner in rats. GABA (GABA, B.D.H. Ltd.) alone in a dose of 2,000 mg/kg (IP) also induced catalepsy. The results may be due to partial access of blood-borne GABA to the CNS, leading to inhibition of nigro-striatal dopaminergic neurons involved in the functioning of the corpus striatum.
References
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmacol. 11, 303–314 (1970)
Andén, N.-E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra. Naunyn Schmiedebergs Arch. Pharmacol. 279, 89–92 (1973)
Bartholini, G., Stadler, H.: Cholinergic and GABA-ergic influences on the dopamine turnover in extrapyramidal system. In: Chemical tools in catecholamine research, vol. II. Regulation of catecholamine turnover, O. Almgren, A. Carlsson, and J. Engel, eds., pp. 235–241. Amsterdam: North Holland 1975
Biswas, B., Carlsson, A.: The effect of intraperitoneally administered GABA on brain monoamine metabolism. Naunyn Schmiedebergs Arch. Pharmacol. 299, 47–51 (1977)
Biswas, B., Carlsson, A.: Effect of intraperitoneally administered GABA on the locomotor activity of mice. Psychopharmacology 59, 91–94 (1978)
Carlsson, A., Lindqvist, M.: Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. 20, 140–144 (1963)
Collins, G. G. S.: Effect of aminooxyacetic acid, thiosemicarbazide and haloperidol on the metabolism and half-lives of glutamate and GABA in rat brain. Biochem. Pharmacol. 22, 101–111 (1973)
Costall, B., Naylor, R. J.: Mesolimbic involvement with behavioural effects indicating antipsychotic activity. Eur. J. Pharmacol. 27, 46–58 (1974)
Fisher, R., Norris, J. W., Gilka, L.: GABA in Huntington's chorea. Lancet I, 506, (1974)
Haefely, W., Kulcsár, A., Möhler, H., Pieri, L., Polc, P., Schaffner, R.: Possible involvement of GABA in the central actions of benzodiazepines. In: Mechanism of action of benzodiazepines, E. Costa and P. Greengard, eds., pp. 131–151. New York: Raven Press 1975
Hawkins, J. E., Sarett, L. H.: On the efficacy of aspargine, glutamine, γ-aminobutyric acid and 2-pyrrolidinone in preventing chemically induced seizures in mice. Clin. Chim. Acta 2, 48 (1957)
Keller, H. H., Schaffner, R., Haefely, W.: Interactions of benzodiazepines with neuroleptics at central dopamine neurones. Naunyn Schmiedebergs. Arch. Pharmacol. 294, 1–7 (1976)
Kuriyama, K., Sze, P. Y.: Blood brain barrier to H3-γ-aminobutyric acid in normal and aminooxyacetic acid treated animals. Neuropharmacology 10, 103–108 (1971)
Morroni, O. B.: Immediate clinical results with gammaaminobutyric acid B6 in schizophrenias and deliriums. Sem. Med. (B Air) 123, 892–900 (1963)
Randrup, A., Munkvad, I.: Behavioural stereotypies induced by pharmacological agents. Pharmacopsychiatr. Neuropsychopharmakol. 1, 18–26 (1968)
Roberts, E.: A model of the vertibrate nervous system based on distribution: a key role of the GABA system. In: Neurohumoral coding of brain function, R. D. Myers, ed., pp. 419–449. New York: Plenum 1974
Saad, S. F.: Pharmacological actions of gamma-aminobutyric acid, a review article. Mater Med. Pol. 10, 46–53 (1978)
Tower, D. B.: The administration of gammaaminobutyric acid to man: systemic effects and anticonvulsant action. In: Inhibition in the nervous system and gammamminobutyric acid, E. Roberts, C. F. Baxter, A. V. Harreveld, C. A. G. Wiersman, W. R. Adey, and K. F. Killam, eds., pp. 562–577. New York: Fergamon 1960
Worms, P., Willigens, M. T., Lloyd, K. G.: GABA involvement in neuroleptic-induced catalepsy. J. Pharm. Pharmacol. 30, 716–718 (1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Balsara, J.J., Jadhav, J.H. & Chandorkar, A.G. Effect of intraperitoneally administered GABA on haloperidol-induced catalepsy in the rat. Psychopharmacology 68, 105–107 (1980). https://doi.org/10.1007/BF00426658
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426658